Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
It is not possible to calculate the future cash flow value for
Bucephalus Capital. This is due to cash flow or dividend data being
unavailable. The share price is
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.
The amount the stock market is willing to pay for
is considered below, and whether this is a fair price.
Price based on past earnings
Bucephalus Capital's earnings available for a low price, and how does
this compare to other companies in the same industry?
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bucephalus Capital has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have past financial data. You can see them here.
Show me the analysis anyway
The future performance of a company is measured in the same way as past
performance, by looking at estimated
and how much profit it is expected to make.
Future estimates come from
professional analysts. Just like forecasting the weather, they don’t always get
Expected Diversified Financial industry annual growth in earnings.
Earnings growth vs Low Risk Savings
expected to grow at an
Unable to compare Bucephalus Capital's earnings growth to the low risk savings rate as no estimate data is available.
Growth vs Market Checks
Unable to compare Bucephalus Capital's earnings growth to the Canada market average as no estimate data is available.
Unable to compare Bucephalus Capital's revenue growth to the Canada market average as no estimate data is available.
Unable to determine if Bucephalus Capital is high growth as no earnings estimate data is available.
Unable to determine if Bucephalus Capital is high growth as no revenue estimate data is available.
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can
be gauged below. We look back 3 years and see if they were any good at
predicting what actually occurred. We also show the highest and lowest estimates
looking forward to see if there is a wide range.
Bucephalus Capital's performance over the past 5 years by checking for:
Has earnings increased in past 5 years? (1 check)
Has the earnings growth in the last year exceeded that of the
industry? (1 check)
Is the recent earnings growth over the last year higher than the average annual growth over the
past 5 years? (1 check)
Is the Return on Equity (ROE) higher than 20%? (1 check)
Is the Return on Assets (ROA) above industry average? (1 check)
Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent
earnings report. Some checks require at least 3 or 5 years worth of data.
has a total score of
0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
A company's financial position is much like your own financial position,
it includes everything you own
The boxes below represent the relative size of what makes up
Bucephalus Capital's finances.
The net worth of a company is the difference between its assets and liabilities.
Bucephalus Capital is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
Bucephalus Capital has no long term commitments.
This treemap shows a more detailed breakdown of
Bucephalus Capital's finances. If any of them are yellow this
indicates they may be out of proportion and red means they relate to one of the
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
Low level of unsold assets.
Bucephalus Capital has no debt, it does not need to be covered by short term assets.
Nearly all companies have debt. Debt in itself isn’t
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.
The graphic below shows equity (available funds) and debt, we ideally want to
see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and
whether the level has increased over the past 5 years.
Management is one of the most important areas of a company. We look at
unreasonable CEO compensation, how long the team and board of directors have
been around for and insider trading.
TENURE AS CEO
Mr. Lucas G. Ewart has been Chief Executive Officer and Director of Bucephalus Capital Corp. since February, 2018. Mr. Ewart has extensive experience in finance, senior management and corporate development of public and private companies. He has served as Chairman, CEO as well as Chief Restructuring Officer of numerous companies on an international scale having worked in Canada, USA, Australia, Mexico, and South East Asia (Hong Kong, Singapore, Philippines and China). In addition he served as a Principal to GC-Global Capital Corp. for 10 years which specialized in securitized bridge loans. He served as the Chairman of the Board and President of Bison Gold Exploration Inc. Mr. Ewart served as the Chief Executive Officer of Bison Gold Exploration Inc. since August 14, 2007 until July 2012. Mr. Ewart served as a Consultant of GC-Global Capital Corp., since 2005, where he managed the Investment Banking activities. He served as Vice President of Yoho Resources Inc. since June 2002. Mr. Ewart served as the Chief Executive Officer of E&E Capital Funding Inc., an affiliate of GC Global Capital Corp. since May 2005. He served as Research Analyst of Thomas Kernaghan & Company Ltd. Mr. Ewart was previously involved in many aspects of corporate and developmental finance with a number of brokerage firms and Investment banks in Australia, Canada and Europe. He served as the Chairman and Chief Executive Officer at Virgin Metals Inc. from August 2009 to June 24, 2010. Mr. Ewart has been Chairman of the Board of J.E.M. Capital Corporation since September 1997. He served as a Director for Bison Gold Exploration Inc. since August 2007. He served as a Director of NWM Mining Corporation from November 2006 to September 2010. Mr. Ewart served as a Director of Yoho Resources Inc., VoiceIQ Inc., Auspript PTY, Spark and Canon PTY from April 2002 to December 2004. He served as a Director of E&E Capital Funding Inc. since April 5, 2004. Mr. Ewart served as a Director of Virgin Metals Inc. since August 2009.
Insufficient data for Lucas to compare compensation growth.
Insufficient data for Lucas to establish whether their remuneration is reasonable compared to companies of similar size in Canada.
CFO & Corporate Secretary
CEO, President & Director
Board of Directors Tenure
Average tenure and age of the
board of directors in years:
The tenure for the Bucephalus Capital board of directors is about average.
Board of Directors
CEO, President & Director
Who owns this company?
Recent Insider Trading
No 3 month open market individual insider trading information.
Bucephalus Capital Corp. provides various merchant banking services to micro and small-cap companies in North America. The company offers private and public companies with working capital in the form of common equity, preferred shares, convertible debt, and bridge loans across various industries, such as oil and gas, mining, real estate, manufacturing, retail, financial services, technology, and biotechnology. It is also involved in developing mergers and acquisitions, providing operational management support, and structuring and negotiating debt and equity placements. The company was formerly known as Bradstone Capital Corp. and changed its name to Bucephalus Capital Corp. in April 2019. The company is based in Toronto, Canada. Bucephalus Capital Corp. is a subsidiary of Fountain Asset Corp.
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.